Siamak Baharloo
Siamak Baharloo is a Boston-based entrepreneur who is a Doctor of Philosophy (Human/Medical Genetics) and CEO of Labviva, a SaaS company in the healthcare purchasing space.[1] Baharloo founded the company in 2017 and raised significant funds from MassVentures, Village Global, Glasswing Ventures,[2] and Tech Coast Angels.[3] He is best known for his advocacy for platform tools for complex business such as biopharmaceutical research.[4]
Siamak Baharloo | |
---|---|
Alma mater | University of Maryland, Baltimore County, University of California, San Francisco |
Employer | Labviva |
Title | Co-Founder and CEO |
Education and research
Baharloo earned a B.A.S.c (B.A.Sc.) in Biochemistry and Molecular Biology from the University of Maryland, Baltimore County and a Ph.D. in genetics from the University of California, San Francisco. While at UCSF, he performed extensive genetic research and published papers on many of his findings, including work regarding Byler syndrome,[5] intrahepatic cholestasis,[6] and bipolar disorder[7] His work remains well-cited.[8] His graduate dissertation explored the genetic basis for perfect pitch and was based on a study of 500 musicians. Baharloo's work found evidence that the some of the ability to instantly recognize musical notes is inherited.[9]
Baharloo is the holder or co-holder of several patents related to the intersection of scientific protocols and commerce.[10]
Business career
After working on a genetic mapping project that extensively leveraged technology, rather than staying in academia, Baharloo pursued a business career specializing in e-business and e-commerce for the healthcare industry.[11] He worked for large healthcare organizations like Merck Group[12] and Thermo Fisher Scientific[13] in an executive capacity before going on to found his own company.[14]
References
- "Organization: Labviva". Crunchbase. Crunchbase Inc. Retrieved 12 November 2020.
- "Glasswing Ventures Invests in Five Pre-Seed Frontier Tech Startups". Medium. Glasswing Ventures. Retrieved 12 November 2020.
- Fidler, Kimber. "Tech Coast Angels Invest More Than $9.7 Million in 31 Companies in 1H 2020". PR Web. Tech Coast Angels. Retrieved 12 November 2020.
- "Old Businesses Must Learn New Platform Tricks to Survive". Medium. MIT Initiative on the Digital Economy. Retrieved 17 November 2020.
- Bull, Laura Nanine (1997). "Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): Evidence for heterogeneity". Hepatology (Baltimore, Md.). Hepatology. 26 (1): 155–64. doi:10.1002/hep.510260121. PMID 9214465. S2CID 35040329. Retrieved 12 November 2020.
- Houwen, Roderick H. J. (1994). "Genome screening by searching for shared segments: Mapping a gene for benign recurrent intrahepatic cholestasis". Nature Genetics. 8 (4): 380–6. doi:10.1038/ng1294-380. PMID 7894490. S2CID 8131209. Retrieved 12 November 2020.
- McInnis, L. Alison. "A complete genome screen for genes predisposing to severe bipolar disorder in 2 Costa Rican pedigrees". Research Gate. Proceedings of the National Academy of Sciences. Retrieved 12 November 2020.
- Semantic Scholar. Allen Institute for AI https://www.semanticscholar.org/author/S.-Baharloo/4657326. Retrieved 12 November 2020. Missing or empty
|title=
(help) - Daly, Michael. "Science : Keeping perfect pitch in the family". New Scientist. New Scientist LTD. Retrieved 19 November 2020.
- "Patents by Inventor Siamak Baharloo". Justia. Justia. Retrieved 19 November 2020.
- "SIAMAK BAHARLOO PH.D." Early.com. EARLEY INFORMATION SCIENCE, INC. Retrieved 12 November 2020.
- Hoff, Gregg. "New Data Visualization Application Aims to Accelerate Lead Discovery". PR Web. Cision. Retrieved 12 November 2020.
- "Platform Economy Summit". Informa. Infrorma Connect. Retrieved 12 November 2020.
- Thomas, Lynda. "New Digital Marketplace for Life Science Products – Built with Scientists in Mind". Business Wire. Berkshire Hathaway. Retrieved 12 November 2020.